DIRS.INFO The most relevant business & tech news

President Joe Biden's administration has said it plans to appeal the 5th Circuit's decision as well. The 5th Circuit's decision partially sided with the anti-abortion groups and doctors who challenged mifepristone. In April, the Supreme Court granted emergency requests by the Justice Department and the pill's manufacturer Danco Laboratories to put on hold Kacsmaryk's order while litigation continued. Mifepristone is taken with another drug called misoprostol to perform medication abortion, which accounts for more than half of all U.S. abortions. Since last year's Supreme Court decision, at least 14 U.S. states have put in place outright abortion bans while many others prohibit abortion after a certain length of pregnancy.

Persons: Evelyn Hockstein, mifepristone, Joe Biden's, Jessica Ellsworth, Circuit upended, Matthew Kacsmaryk, Roe, Wade, Andrew Chung, Will Dunham Organizations: Alamo Women's, REUTERS, U.S, Supreme, Danco Laboratories, New, Circuit, U.S . Food, Drug Administration, FDA, Justice Department, mifepristone, Republican, Alliance for Hippocratic Medicine, Defending, Thomson Locations: Carbondale , Illinois, U.S, New Orleans, Amarillo , Texas, New York

☆ Abortion pill company asks Supreme Court to decide mifepristone case
▼ + stars: | 2023-09-08 | by ( Spencer Kimball | ) www.cnbc.com time to read: +1 min

Drug company Danco Laboratories on Friday asked the Supreme Court to review the case challenging the legality of the abortion pill mifepristone. Danco, which distributes the abortion pill, wants the Supreme Court to reverse the lower court ruling. Danco's request for the Supreme Court to take up the case comes nearly 15 months after the court's conservative majority overturned Roe v. Wade, the landmark 1973 decision that protected abortion as a constitutional right. Four justices have to agree to take up the abortion pill case. The U.S. Department of Justice is also expected to ask the high court to review the case.

Persons: Roe, Wade Organizations: Danco Laboratories, U.S ., Appeals, Fifth Circuit, U.S . Department of Justice

Boxes of Mifepristone, the first pill in a medical abortion, are seen at Alamo Women's Clinic in Carbondale, Illinois, U.S., April 20, 2023. Circuit Court of Appeals means for doctors and patients:CAN PATIENTS STILL GET THE ABORTION PILL? WHAT IS MEDICATION ABORTION? Medication abortion is a two-drug regimen consisting of mifepristone followed by misoprostol used to terminate a pregnancy within the first 10 weeks. If the ruling is upheld, doctors could still prescribe the abortion pill, but with restrictions.

Persons: Evelyn Hockstein, mifepristone, misoprostol, Wade, Matthew Kacsmaryk, Danco, GenBioPro, Brendan Pierson, Noeleen Walder, Lisa Shumaker Organizations: Alamo Women's, REUTERS, New, Circuit, U.S, Supreme, Danco Laboratories, FDA, Hippocratic Medicine, U.S . Food, Drug Administration, District, Thomson Locations: Carbondale , Illinois, U.S, New Orleans, United States, Texas, Amarillo , Texas

☆ Appeals court imposes restrictions on abortion pill, but drug will stay on the market for now
▼ + stars: | 2023-08-16 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

A federal appeals court on Wednesday imposed restrictions on the abortion pill mifepristone, though the ruling will not have an immediate impact. The ruling by the U.S. 5th Circuit Court of Appeals is paused from taking effect until the Supreme Court makes a decision about the case. The appeals court Wednesday ruled that the several decisions the Food and Drug Administration took to make the abortion pill more broadly available to women were illegal. If the Supreme Court upholds Wednesday's ruling, women would no longer be able to obtain the abortion pill by mail. That is basically the narrative you all are putting forth — nobody should ever question the FDA," Ho said during the hearing.

Persons: Biden, Jennifer Walker Elrod, Judge James Ho, mifepristone, Roe, Wade, Elrod, George W, Bush, Ho, Cory Wilson, Donald Trump, Danco Organizations: Alamo Women's, U.S, and Drug Administration, FDA, Food, Circuit, Danco Laboratories, Alliance for Hippocratic Medicine, Republican Locations: Carbondale , Illinois, U.S

REUTERS/Evelyn Hockstein/File PhotoWILMINGTON, Delaware, June 29 (Reuters) - A prominent U.S. lawsuit to ban the abortion pill mifepristone has focused on the drug's safety and approval process. Skop and 10 other doctors submitted their testimony when the case began in November. She said she was harmed by the FDA expanding access to the pill because she has treated dozens of women at her hospital's emergency room with mifepristone complications. Erin Hawley, an attorney with the Alliance Defending Freedom legal organization representing the plaintiffs, said abortion sets the case apart. In the abortion pill case, the two initial court rulings found harm to Skop and other doctors was "impending" because the mifepristone label says the treatment may be unsuccessful in up 7% of women.

Persons: Evelyn Hockstein, mifepristone, Ingrid Skop, Roe, Wade, Skop, doesn’t, Leah Litman, Erin Hawley, Hawley, Matthew Kacsmaryk, Samuel Alito's, Danco, Tom Hals, Amy Stevens, Deepa Babington Organizations: Alamo Women's, REUTERS, U.S . Food, Drug Administration, Supreme, FDA, University of Michigan Law School, Alliance Defending, Alliance for Hippocratic, District, Appeals, U.S, Fifth, Amnesty International, Danco Laboratories, Thomson Locations: Carbondale , Illinois, U.S, WILMINGTON , Delaware, Texas, America, Amarillo , Texas, Amarillo, New Orleans, Louisiana, United States, Wilmington , Delaware

May 17 (Reuters) - Federal appeals court judges appeared to express support on Wednesday for opponents of the abortion pill mifepristone to pursue their challenge to its U.S. approval, which has potentially far-reaching consequences for abortion access across the country. Circuit Court of Appeals in New Orleans to overturn last month's unprecedented ruling by U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas suspending mifepristone's approval. [1/2] A patient prepares to take Mifepristone, the first medication in a medical abortion, at Alamo Women's Clinic in Carbondale, Illinois, U.S., April 20, 2023. Circuit Judges James Ho and Wilson were appointed by Donald Trump. SAFE AND EFFECTIVEMifepristone remains available for now, following an emergency order from the U.S. Supreme Court putting Kacsmaryk's order on hold during the appeal.

[1/2] A patient prepares to take Mifepristone, the first medication in a medical abortion, at Alamo Women's Clinic in Carbondale, Illinois, U.S., April 20, 2023. REUTERS/Evelyn Hockstein/File PhotoMay 17 (Reuters) - U.S. appeals court judges began hearing arguments on Wednesday in a legal battle over the availability of the abortion pill mifepristone, with potentially far-reaching consequences for abortion access across the United States. Circuit Court of Appeals in New Orleans to overturn last month's unprecedented ruling by U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas suspending mifepristone's approval. Danco Laboratories, which sells the drug under the brand name Mifeprex, is also expected to argue before the court. The emergency room doctors said they were being forced to complete surgical abortions, which was against their conscience, for women who took the pill and failed to complete a medical abortion.

☆ NJ Gov. Murphy would consider defying Supreme Court if justices back abortion pill ban
▼ + stars: | 2023-05-17 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Phil Murphy on Wednesday said he would consider defying the Supreme Court and continue to provide mifepristone if the court rules in favor of a ban on the abortion pill. When asked if the state would prescribe mifepristone after such a ruling, Murphy told MSNBC: "To be determined." It's going to cost them health, it's also going to cost peoples' lives, women in particular sadly. That's what's at stake, we'll do whatever it takes to save lives," said Murphy, a Democrat. The case hinges on whether the Food and Drug Administration's approval of the abortion pill should be rolled back.

[1/2] A patient prepares to take Mifepristone, the first medication in a medical abortion, at Alamo Women's Clinic in Carbondale, Illinois, U.S., April 20, 2023. REUTERS/Evelyn Hockstein/File PhotoMay 17 (Reuters) - A federal appeals court in New Orleans will hear arguments on Wednesday in a closely watched case brought by anti-abortion activists seeking to ban the abortion pill mifepristone, with potentially far-reaching impact on abortion access across the United States. Circuit Court of Appeals to overturn last month's unprecedented ruling by U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas suspending mifepristone's FDA approval. Mifepristone remains available for now, following an emergency order from the U.S. Supreme Court putting Kacsmaryk's order on hold during the appeal. Whichever way the 5th Circuit panel rules, the decision is sure to be appealed, first to the full court and then to the U.S. Supreme Court.

May 8 (Reuters) - A case brought by anti-abortion groups seeking to ban the abortion pill mifepristone nationwide will be heard next week by a panel of three deeply conservative judges hostile to abortion rights, a federal appeals court revealed on Monday. Circuit Court of Appeals panel in New Orleans on May 17 to overturn a court order that suspended the federal government's approval of mifepristone. The U.S. Supreme Court put that order on hold, meaning that mifepristone remains available while the case is appealed. In 2021, Ho was in the majority in a 2-1 ruling refusing to block Texas's six-week abortion ban. Wilson, another Trump appointee, as a state legislator voted to ban abortion once fetal cardiac activity is detected, around six weeks.

Circuit Court of Appeals, called the April 7 order by U.S. District Judge Matthew Kacsmaryk "abrupt and profoundly disruptive." The 5th Circuit is preparing to hear May 17 arguments on the matter after the U.S. Supreme Court last week put on hold Kacsmaryk's order. Danco Laboratories, which manufactures the brand-name version of the drug, was due to make a separate filing with the 5th Circuit. A panel of three 5th Circuit judges is scheduled to hear arguments on whether to uphold Kacsmaryk's order. The 5th Circuit has a conservative reputation, with 12 of its 16 active judges appointed by Republican presidents.

However the 5th Circuit rules, the case will likely continue for months or years. HOW DID THE CASE GET TO THE 5TH CIRCUIT? WHAT COULD THE 5TH CIRCUIT DO? No matter what the court does, the losing party will have a chance to appeal to the full 5th Circuit and then to the U.S. Supreme Court. Once it does come, the losing side will again have the chance to appeal to the 5th Circuit and, eventually, the Supreme Court.

HOW DID THE CASE GET TO THE SUPREME COURT? The Biden administration and Danco immediately asked the Supreme Court to overrule the 5th Circuit and impose an emergency stay. WHAT DID THE SUPREME COURT DO? The injunction was not at issue before the Supreme Court, and remains in effect. Once it does come, the losing side will again have the chance to appeal to the 5th Circuit and, eventually, the Supreme Court.

☆ Supreme Court says abortion pill mifepristone will remain broadly available during legal battle
▼ + stars: | 2023-04-21 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

Demonstrators rally in support of abortion rights at the US Supreme Court in Washington, DC, April 15, 2023. The Supreme Court on Friday ordered the abortion pill mifepristone to remain broadly available as litigation plays out in a lower court. The appeals court has scheduled oral arguments for Wednesday, May 17 at 1 pm CT. Mifepristone has become the central flashpoint in the legal battle over abortion since the Supreme Court last summer overturned Roe v. Wade, the landmark 1973 decision that guaranteed abortion as a constitutional right nationwide. The appeals court judges also suspended the 2019 approval of the generic version of mifepristone.

The Supreme Court, which has a 6-3 conservative majority, is expected to act before the deadline to either grant or reject the requests or further pause the litigation. The Food and Drug Administration (FDA), the U.S. agency that signs off on the safety of food products, drugs and medical devices, approved mifepristone in 2000. Circuit Court of Appeals on April 12 declined to block the curbs ordered by Kacsmaryk. Anti-abortion groups led by the recently formed Alliance for Hippocratic Medicine and four anti-abortion doctors sued the FDA in November. The plaintiffs contend that the agency used an unlawful process to approve the drug, which they consider to be dangerous.

☆ Read the Supreme Court’s Order on Abortion Pill Access
▼ + stars: | 2023-04-21 | by ( ) www.nytimes.com time to read: +2 min

2 DANCO LABORATORIES, LLC v. ALLIANCE FOR HIPPOCRATIC MEDICINE ALITO, J., dissenting Whole (2021) op., at 2). In another, we were criticized for ruling on a stay application while "barely bother[ing] to explain [our] conclusion," a disposition that was labeled as “emblematic of too much of this Court's shadow-docket decisionmaking— which every day becomes more unreasoned." Woman's Health v. Jackson, 594 U. S. (KAGAN, J., dissenting from denial of application for injunctive relief) (slip op., at 1-2). Barr v. East Bay Sanctuary Covenant, 588 U. S. (2019) (SOTOMAYOR, J., dissenting) (slip op., at 5). It would simply restore the circumstances that existed (and that the Government defended) from 2000 to 2016 under three Presidential administrations.

☆ Supreme Court protects access to abortion pill
▼ + stars: | 2023-04-21 | by ( Ariane De Vogue | ) edition.cnn.com time to read: +7 min

CNN —The Supreme Court on Friday protected access to a widely used abortion drug by freezing lower-court rulings that placed restrictions on its usage. How the dispute over medication abortion is ultimately resolved could make it more difficult for women to obtain abortion, even in the states that still allow it. At issue is the scope of FDA’s authority to regulate mifepristone, a drug that the medical community has deemed safe and effective. The next step in the litigation will be a hearing in front of a New Orleans-based federal appeals court on May 17. The appeals court ultimately let stand the government’s approval of the drug, but agreed with Kacsmaryk that access could be limited.

☆ Supreme Court Action Expected in Abortion-Pill Case
▼ + stars: | 2023-04-19 | by ( Laura Kusisto | Jess Bravin | ) www.wsj.com time to read: 1 min

Photo illustration: Ryan TrefesWASHINGTON—The Supreme Court is expected to issue an order as soon as Wednesday that could determine the availability of the widely used abortion pill mifepristone for at least the next several months. The justices are considering emergency appeals from the Biden administration and Danco Laboratories LLC, the brand-name manufacturer of the pill, to keep the drug on the market during ongoing litigation over its approval more than 20 years ago by the Food and Drug Administration. Antiabortion groups filed a lawsuit in November challenging the original approval and more recent regulations that made the pill, which is used in more than half of abortions, easier to obtain.

☆ US Supreme Court faces self-imposed deadline to act on abortion pill curbs
▼ + stars: | 2023-04-19 | by ( Andrew Chung | ) www.reuters.com time to read: +3 min

WASHINGTON, April 19 (Reuters) - The U.S. Supreme Court on Wednesday faces a self-imposed deadline to act before significant limits on access to the abortion pill mifepristone take effect in a challenge by anti-abortion groups to the drug's federal regulatory approval. The Supreme Court, which has a 6-3 conservative majority, is expected to act before the deadline to either grant or reject the requests or further pause the litigation. In a case that could undercut federal regulatory authority over drug safety, the New Orleans-based 5th U.S. The 5th Circuit did halt a part of Kacsmaryk's order that would have suspended the U.S. Food and Drug Administration (FDA) approval of the drug in 2000 and effectively pull it off the market. Some 56% of respondents said they have an unfavorable view of the Supreme Court.

☆ Supreme Court extends suspension of Texas ruling limiting access to abortion pill mifepristone
▼ + stars: | 2023-04-19 | by ( Associated Press | ) www.businessinsider.com time to read: +5 min

The Supreme Court gave itself more time to consider whether to allow restrictions on abortion pill mifepristone to take effect. Legal challenges to mifepristone's FDA approval continue. The justices had given themselves a deadline on Wednesday in a fast-moving case from Texas in which abortion opponents are seeking to roll back FDA approval mifepristone. Even as the abortion landscape changed dramatically in several states, abortion opponents set their sights on medication abortions, which make up more than half of all abortions in the United States. Mifepristone has been available for use in medication abortions in the United States since the FDA granted approval in 2000.

HOW DID IT REACH THE SUPREME COURT? Whether or not the Supreme Court decides to stay Kacsmaryk's order, it will not decide the merits of the case. The Biden administration said in its petition to the Supreme Court that the FDA cannot comply with both orders. WHAT HAPPENS AFTER THE SUPREME COURT RULES? Once it does come, the losing side will again have the chance to appeal to the 5th Circuit and, eventually, the Supreme Court.

☆ Supreme Court maintains full access to abortion pill mifepristone until at least Friday
▼ + stars: | 2023-04-19 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

Demonstrators rally in support of abortion rights at the US Supreme Court in Washington, DC, April 15, 2023. Supreme Court Justice Samuel Alito on Wednesday issued an order allowing the abortion pill mifepristone to remain available by mail delivery and without tighter restrictions on how it is used until at least late Friday night. Although that ruling keeps mifepristone on the market, the restrictions are so sweeping that many women would not have access to the medication even in some states where abortion is legal. The appeals court restrictions included blocking mail delivery of the medication, re-imposing doctor visits as a requirement to obtain the drug, and shortening the length of time women can use the pill to the seventh week of pregnancy. The court also blocked the generic version of mifepristone made by a second company, GenBioPro, which supplies about two-thirds of the medication for the U.S. market.

☆ Abortion pill company GenBioPro asks U.S. court to keep generic mifepristone on market
▼ + stars: | 2023-04-19 | by ( Spencer Kimball | ) www.cnbc.com time to read: +2 min

GenBioPro asked the U.S. District Court for Maryland to preemptively block the FDA from pulling the company's 2019 approval to distribute the company's version of mifepristone. GenBioPro has said in court filings that it supplies two-thirds of the mifepristone used in the U.S. for abortions. "GenBioPro will use all regulatory and legal tools to protect access to mifepristone for patients and providers." The Supreme Court last week temporarily put the appeal's court rulings on hold. But the Supreme Court as early as Wednesday could move to lift that ban or leave it in place pending further legal challenges to the rulings

☆ Anti-abortion groups urge US Supreme Court to restrict abortion pill
▼ + stars: | 2023-04-18 | by ( Andrew Chung | ) www.reuters.com time to read: +4 min

WASHINGTON, April 18 (Reuters) - The U.S. Supreme Court should restrict the availability of the abortion pill mifepristone, anti-abortion groups challenging the medication's federal regulatory approval told the justices in a filing on Tuesday, urging them to implement curbs ordered by a conservative federal judge in Texas. Mifepristone is taken with another drug called misoprostol to perform medication abortion, which now accounts for more than half of all U.S. abortions. The Supreme Court has a 6-3 conservative majority. Anti-abortion groups led by the recently formed Alliance for Hippocratic Medicine and four anti-abortion doctors sued the FDA in November seeking to reverse approval of mifepristone. Since last year's Supreme Court decision, 12 U.S. states have put in place outright bans while many others prohibit abortion after a certain length of pregnancy.

☆ Anti-abortion group asks Supreme Court to keep mifepristone restrictions
▼ + stars: | 2023-04-18 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

Anti-abortion demonstrators celebrate outside the United States Supreme Court as the court rules in the Dobbs v Women's Health Organization abortion case, overturning the landmark Roe v Wade abortion decision in Washington, U.S., June 24, 2022. An anti-abortion group on Tuesday asked the Supreme Court to keep restrictions on the abortion pill mifepristone in place while the battle over the medication's legal status plays out. Supreme Court Justice Samuel Alito on Friday temporarily blocked those restrictions until 11:59 p.m. The anti-abortion organization also said the court should consider whether the FDA properly approved mifepristone in 2000 if it takes the case. If the lower court rulings against mifepristone ultimately stand, access to abortion could face restrictions even in some states where the procedure remains legal.

Search resuls for: "Danco Laboratories"

25 mentions found